Muhammad Umair Mushtaq, Associate Professor of Medicine at University of Kansas Medical Center, shared a post on LinkedIn:
“Allogeneic hematopoietic stem cell transplantation can be done in elderly myelofibrosis patients with over 50% two-year survival. Careful patient selection is critical.”
Proceed to the video attached to the post.
More posts featuring Muhammad Umair Mushtaq.